Sign In

James Mawson

Dad and CEO/Founder of GCV (Global Corporate Venturing)&GUV

James Mawson is the Founder and CEO of Mawsonia, a media company known for producing Global Corporate Venturing and Global University Venturing, which offer news, data, and training on supporting and investing in entrepreneurial ventures.

He is a prolific writer and co-author of two books exploring innovation capital and the entrepreneurial ecosystem, with a forthcoming publication, 'Innovation Paradox,' scheduled for release in 2024 by Oxford University Press and Hurst.

James Mawson brings over two decades of experience in journalism, having written for prestigious publications like the Wall Street Journal, Financial Times, and Harvard Business Review, among others.

His expertise extends to serving as a seasoned non-executive director and chairman across various media and philanthropic organizations, showcasing a wealth of board-level knowledge in the industry.

He holds a Bachelor's degree in War Studies and History from King's College London and has a background in editing and reporting for renowned media outlets.

James Mawson's specialties encompass CEO roles, non-executive positions, editorial work, and expertise in business, finance, entrepreneurship, innovation, venture capital, private equity, defense, and corporate venturing.

He has been associated with key organizations like Mawsonia, RADAR AI Limited, London Press Club, and European Venture Philanthropy Association, where he held editorial, authorship, and directorial roles.

Highlights

Aug 28 · linkedin

Lots of new venture funds being formed around the healthcare ecosystem with Australia’s oldest medical research institute – the Walter and Eliza Hall Institute of Medical Research (WEHI) – setting up the 66ten fund under Anne-Laure Puaux https://lnkd.in/eeqkq_D4 and Ben Freeberg raising an initial $30m for Oncology Ventures' first fund including strategic limited partners from Cardinal Health, City of Hope and Moffitt Cancer Center. https://lnkd.in/e9Q_BDxq

I'm honoured to be helping explore the dynamic role of hospital venture funds and uncover insights from industry leaders on future healthcare investments at the World Medical Innovation Forum in Boston next month H/T Chris Coburn https://lnkd.in/eRPgrSvD

With an expert panel of Roger Kitterman, SVP, Ventures and Business Development & Licensing, and Managing Partner, Mass General Brigham Ventures; Tim Luker PhD, VP Ventures and West Coast Head, Eli Lilly; Rahul Ballal PhD, CEO, Mediar Therapeutics; Shawnalea Frazier, PhD, AbbVie Ventures; and Aaron Nelson, Novartis Venture Fund to help understand current trends, unique strategies, successful partnerships that drive innovation, and impactful case studies highlighting challenges and opportunities.

As GCV editor Maija Palmer noted in this week's Blueprint newsletter https://lnkd.in/eCxZkWkw there's a lot of dynamic activity in the sector with Novartis backing a $150m series A funding round for Borealis, which is developing next-generation RNA treatments for kidney disease, and consolidation in the telehealth sector with the $525m acquisition of digital pharmacy company Truepill by Ireland’s LetsGetChecked - both backed by Optum Ventures, and a $10m raise for protein startup David backed by Valor Siren Ventures, which has anchor investments from Starbucks, Nestlé, and a suite of Fortune 500 food and retail organisations.

Our report last year into functional foods  started tracking this growing trend for foods with benefits but let's see if conference food and hospitals have caught up with the trend... https://lnkd.in/eXYVWgA4

Jul 27 · linkedin

While there's, rightly, a lot of attention on drones and cyber impacting the battlefields of today, eg Ukraine, and tomorrow (could the US and Japan realistically project power through the China seas to support South Korea and Taiwan if sea drones are effective?) there's still not enough focus on space.

India's budget will give its space department 10 billion rupees ($120m) to set up a venture capital fund to support projects that will expand the country's space economy fivefold in the next 10 years. And in Japan, Toyoda Gosei has invested in Letara, a startup out of Hokkaido University that develops engines for artificial satellites. H/T Edison and Kim https://lnkd.in/eVa7Buau

In Europe, Nato is backing Alpine Space Ventures and Join Capital to support space and deep-tech startups and Eutelsat and other CVCs are backing UK-based VC Seraphim Space. Between Asia, Europe and the US broadly equal numbers of VC and PE deals have been struck since 2020, according to S&P but as the geopolitical struggles heats up expect this to increase further - if not to infinity and beyond https://lnkd.in/eBViPgxq

Here's some from the GCV Symposium to keep an eye on: https://lnkd.in/egJhjZiC

James Mawson
Add to my network

Location

London, England, United Kingdom